203 related articles for article (PubMed ID: 25743131)
1. [Application of iPSC technology to cancer treatment].
Oshima N; Aoi T
Gan To Kagaku Ryoho; 2015 Feb; 42(2):139-43. PubMed ID: 25743131
[TBL] [Abstract][Full Text] [Related]
2. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
3. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
4. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
5. Advances in cellular reprogramming: moving toward a reprieve from immunogenicity.
Gallegos TF; Sancho-Martinez I; Izpisua Belmonte JC
Immunol Lett; 2013; 155(1-2):14-7. PubMed ID: 24076314
[TBL] [Abstract][Full Text] [Related]
6. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
7. iPS cell technologies and cartilage regeneration.
Tsumaki N; Okada M; Yamashita A
Bone; 2015 Jan; 70():48-54. PubMed ID: 25026496
[TBL] [Abstract][Full Text] [Related]
8. Exploiting pluripotency for therapeutic gain.
Deng W
Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells' self-renewal and pluripotency is maintained by a bovine granulosa cell line-conditioned medium.
Solari C; Losino N; Luzzani C; Waisman A; Bluguermann C; Questa M; Sevlever G; Miriuka S; BaraƱao L; Guberman A
Biochem Biophys Res Commun; 2011 Jul; 410(2):252-7. PubMed ID: 21651896
[TBL] [Abstract][Full Text] [Related]
10. Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species.
Imamura M; Okuno H; Tomioka I; Kawamura Y; Lin ZY; Nakajima R; Akamatsu W; Okano HJ; Matsuzaki Y; Sasaki E; Okano H
Methods Mol Biol; 2012; 925():21-48. PubMed ID: 22907488
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells in research and therapy.
Teoh HK; Cheong SK
Malays J Pathol; 2012 Jun; 34(1):1-13. PubMed ID: 22870592
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine.
Qiao Y; Agboola OS; Hu X; Wu Y; Lei L
Stem Cell Rev Rep; 2020 Dec; 16(6):1049-1061. PubMed ID: 32939647
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
Kang L; Kou Z; Zhang Y; Gao S
J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
[TBL] [Abstract][Full Text] [Related]
14. Clinical therapy using iPSCs: hopes and challenges.
Lu X; Zhao T
Genomics Proteomics Bioinformatics; 2013 Oct; 11(5):294-8. PubMed ID: 24060840
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cell (iPSCs) and their application in immunotherapy.
Jiang Z; Han Y; Cao X
Cell Mol Immunol; 2014 Jan; 11(1):17-24. PubMed ID: 24336163
[TBL] [Abstract][Full Text] [Related]
16. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
Ito D; Okano H; Suzuki N
Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells in medicine and biology.
Takahashi K; Yamanaka S
Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
[TBL] [Abstract][Full Text] [Related]
19. An improved method for the derivation of high quality iPSCs in the absence of c-Myc.
Habib O; Habib G; Choi HW; Hong KS; Do JT; Moon SH; Chung HM
Exp Cell Res; 2013 Dec; 319(20):3190-200. PubMed ID: 24095950
[TBL] [Abstract][Full Text] [Related]
20. iPSC technology: platform for drug discovery. Point.
Ellis J; Bhatia M
Clin Pharmacol Ther; 2011 May; 89(5):639-41. PubMed ID: 21512521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]